CFFN
Capitol Federal Financial, Inc.
CFFN has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
CFFN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CFFN's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CFFN.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CFFN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $8.46 | — |
| Cheap | 13x | $8.40 | -0.7% |
| Current | 13x | $8.46 | — |
| Fair | 15x | $10.01 | +18% |
| Expensive | 21x | $13.83 | +63% |
Historical ranges are pointers, not guarantees.
CFFN has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
CFFN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
CFFN has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CFFN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.78 | +19% |
| Q2 2026 | $0.65 | +38% |
| Q1 2026 | $0.60 | +50% |
| Q4 2025 | $0.56 | +44% |
| Q3 2025 | $0.52 | +79% |
| Q2 2023 | $0.43 | -31% |
| Q1 2023 | $0.53 | -10% |
| Q4 2022 | $0.58 | 0% |
| Q3 2022 | $0.62 | +11% |
CFFN earned $0.65 per share over the past year, up 38% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
CFFN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $60.2M | +19% |
| Q1 2026 | $57.7M | +18% |
| Q4 2025 | $56.8M | +21% |
| Q3 2025 | $54.6M | +20% |
| Q2 2025 | $50.7M | +13% |
| Q1 2025 | $48.8M | +6.2% |
| Q4 2024 | $46.9M | +53% |
| Q2 2024 | $45M | +11% |
CFFN has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 49% | +6 points |
| Q1 2026 | 43% | +4 points |
| Q4 2025 | 44% | +3.7 points |
| Q3 2025 | 42% | +0.1 points |
| Q2 2025 | 43% | +8 points |
| Q1 2025 | 39% | +2 points |
| Q4 2024 | 41% | +34 points |
| Q3 2024 | 42% | N/A |
CFFN has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
CFFN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $15.7M | +46% |
| Q1 2026 | $20.1M | +37% |
| Q4 2025 | $15.8M | +255% |
| Q3 2025 | $19.9M | +$24.7M |
| Q2 2025 | $10.8M | -35% |
| Q1 2025 | $14.7M | -23% |
| Q4 2024 | $4.5M | +$11.1M |
| Q2 2024 | $16.4M | +128% |
CFFN has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CFFN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -2.6M shares |
| 1 year | -4.7% | -6.1M shares |
| 3 years | -6.9% | -9.1M shares |
| 5 years | -8.5% | -11.5M shares |
| Available history | -10% | -13.9M shares |
CFFN has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $14.2M |
| Q1 2026 | $15.8M |
| Q4 2025 | $16M |
| Q3 2025 | $3.9M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $1,000 |
CFFN spent $50M buying back its own shares over the past year, more than ten times what it spent the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CFFN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.2x | Net Cash |
| Q1 2026 | -3.2x | Net Cash |
| Q4 2025 | -2.4x | Net Cash |
| Q3 2025 | 18.7x | High |
| Q2 2025 | -2.0x | Net Cash |
| Q1 2025 | -4.2x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
| Q3 2024 | 31.3x | High |
CFFN has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CFFN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 39.0 | Neutral |
CFFN's weekly RSI is 54 (neutral) and its Stochastic is 39 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CFFN PE vs Financial Services Sector
| Metric | CFFN | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | Same PE |
| PE % | 19 | 63 | 44 pts below |
CFFN has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
CFFN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.44 | 0.2% above |
| 20 week MA | $8.60 | 1.6% below |
| 50 week MA | $7.87 | 7.5% above |
| 100 week MA | $6.92 | 22% above |
| 200 week MA | $6.51 | 30% above |
CFFN's trend is mixed: it's above four of its five weekly moving averages, and 30% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CFFN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.7 | $12.4 | -9.8% |
| 2021 | $12.4 | $11.4 | -8.2% |
| 2022 | $11.4 | $8.60 | -24% |
| 2023 | $8.60 | $6.45 | -25% |
| 2024 | $6.45 | $5.95 | -7.8% |
| 2025 | $5.95 | $7.00 | +18% |
| 2026 YTD | $7.00 | $8.46 | +21% |
CFFN has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.